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Abstract
Approximately 60% to 87% of patients with heart failure (HF) report sexual problems, and numbers as low as 31% of HF
patients younger than 70 have normal sexual function. When compared with healthy elders, the amount of perceived sexual
dysfunction might be similar (around 56%), but patients with HF are reporting more erectile dysfunction (ED) and also perceive
that their HF symptoms (20%) or HF medication (10%) is the cause for their problems. The prevalence of ED is highly prevalent
in men with cardiac disease and reported in up to 81% of cardiac patients, compared with 50% in the general older population.
In total 25–76% of women with HF report sexual problems or concerns.
The physical effort related to sexual activity in cardiac patients can be compared to mild to moderate physical activity. The
related energy expenditure of sexual activity falls in the range of three to ﬁve metabolic units (METs), which can be compared
to the energy needed to climb three ﬂights of stairs, general housework, or gardening.
Information about sexual activity is often overlooked by health care professionals treating HF patients. Advice and counselling
about this subject are needed to decrease worries of patients and partners, avoid skipping medication because of fear for side
effects, or prevent inappropriate use of potency enhancing drugs or herbs.
Introduction
Heart failure (HF) is known to have consequences for physical
function affecting daily life of the patient and his/her partner.
Patients with HF may report a decrease in sexual performance,
a loss of sexual pleasure or satisfaction, a decrease of sexual
interest, and a decrease in the frequency of sex.1–4 For a lot
of HF patients, sexual health is important, with 52% of the
men and 38% of the women with HF reporting that sex was
important and sexual health was impacting their quality of
life.5,6
Although not every patient with HF suffers from sexual
problems and the relationship between the patient and the
partner is not always affected,7 several patients and partners
have questions and worries. They may have questions about
when to resume sexual activity, about possible dangers and
what to do in case symptoms occur. In the American Heart
Association (AHA) scientiﬁc statement on sexual Activity and
Cardiovascular Disease,8 sexual activity is described to be
reasonable for patients with compensated and/or mild
[New York Heart Association (NYHA) class I or II] HF (Class
IIa; Level of Evidence B). Sexual activity is not advised for
patients with decompensated or advanced HF (NYHA class
III or IV) until their condition is stabilized and optimally
managed (Class III; Level of Evidence C).
Although the majority of health care professionals feel a
certain responsibility to discuss patients’ sexual health, in
practice, they seldom address sex with their patients, even
during cardiac rehabilitation or in general practice.9–11
From the patient side, patients also experience barriers to
discuss their worries or questions around sexual function.
Some feel embarrassed to address the topic, others do not
want to embarrass the health care providers, or others fear
that their health care provider is not experienced enough to
understand his/her problems.9,11
Not discussing sexual concerns with patients might lead to
unnecessary worries or sadness of patients. Some patients
even might skip their medication because they fear for side
effects of their cardiac medications. Some patients start using
substances that might help increase their potency or sexual
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desire, without knowing the possible consequences such as
interaction with cardiac medications, vasoactive or
sympathomimetic effects, and elevating or reducing systemic
blood pressure (BP).8
This short summary article addresses the prevalence of
sexual problems in HF patients and factors that are related
to sexual problems and provides some basic information on
energy, risk, and treatment. This information might help
health care providers to address sexual health in their
consultation.
Prevalence of sexual problems in heart
failure patients
Approximately 60% to 87% of patients with HF report sexual
problems.8 These problems include a marked decrease in sex-
ual interest and activity, and one quarter of patients with HF
report that they have stopped sexual activity altogether.1,12
Other studies have found that normal sexual activity was ob-
served only in 31% of patients younger than 70.5 When HF
patients (n = 438) were compared with healthy elders
(n = 459), the self-reported amount of sexual dysfunction
was similar, at 59% and 56%.2 However, HF patients reported
signiﬁcantly more often ED (37% vs. 17%).2 Sexual problems
include a lack of interest in or fear for having sex, orgasmic
difﬁculties, or erectile dysfunction (ED) in men.
ED occurs also in the general population, with increasing
prevalence with age. The prevalence is estimated to be 50%
in 60-year-old men.13,14 But ED is reported in up to 81% of
cardiac patients14 across different cultures and ethnic
groups.15 Although in most studies more male patients report
sexual problems, also women with cardiac disease are known
to have more frequent sexual problems compared with
women in the general population.16,17 Women may experi-
ence other types of sexual dysfunction than men, including
decline in sexual interest or desire, decline in sexual arousal,
orgasmic disorder, or painful sexual intercourse.17 In a gen-
eral population, 27% of women (age 50–59) reported lack
of interest in sexual activity, and 23% of women were not
able to have an orgasm.18 In a HF population, 80% of the
female HF patients reported reduced lubrication and 76%
reported frequent unsuccessful intercourse.16
Some sexual problems already are present prior to the
onset of HF, but such problems also can develop during
different phases in the HF trajectory.6 In a previous study,
27% of the patients without sexual problems at 1month after
discharge developed sexual problems over time. In 70% of
the patients who had difﬁculties at 1month after discharge,
the sexual problems remained. At the same time, 30% of
the patients, who reported sexual problems at 1month after
discharge, did not report difﬁculties in sexual activity at
follow-up.6
Factors related to sexual problems in
heart failure patients
Most patients attribute their sexual problems to their HF
symptoms; they perceived that shortness of breath (20%),
fatigue (20%), medication use (10%), and limited circulation
(11%) are causing their sexual problems.2
However, the mechanism behind sexual problems is
complex. Sexual problems can be related to various
demographic, clinical, and treatment factors5 (Figure 1).
Figure 1 Factors related to sexual problems in heart failure patients.
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HF speciﬁc factors that are related to sexual problems are
HF symptoms such as dyspnea, fatigue, and activity intoler-
ance. In addition, HF patients often suffer from comorbidity;
up to 35% of HF patients suffers from COPD,19 and the overall
prevalence of diabetes in HF is 20–25%.20 These comorbid
conditions are known to be closely related to sexual
problems.5 There is an over threefold increased risk of ED in
diabetic vs. nondiabetic men,21 and diabetic women are more
likely to report problems with lubrication (OR[95%CI] = 2.37
[1.35–4.16]) and orgasm (OR[95%CI] = 1.80[1.01–3.20]) than
nondiabetic women.22
Medication and device therapy
HF medications are often perceived to cause problems
with sexual performance or libido, although newer gener-
ations of drugs appear to have fewer sexual side-effects.
On top of HF medication, other medication is prescribed
for co-morbid or underlying conditions, which might be
the underlying reason for sexual problems.
In particular, thiazide diuretics may impact erectile
function.23 Thiazide diuretics can cause endothelial dys-
function and increased vascular oxidative stress, as well
as hyperlipidemia, insulin resistance, a new onset of dia-
betes mellitus, and stimulation of the sympathetic system
and the renin–angiotensin–aldosterone system. Digoxin
and mineralocorticoid receptor antagonist are also
described to have an effect on sexual performance or
libido.23 Furthermore, the use of beta blockers can reduce
sexual function;8,23 however, data on third generation
beta blockers currently used for HF treatment are inconsis-
tent.23 HF patients have even reported an improvement
of sexual performance with beta blockers, which is likely
to be a result of both a reduction of HF severity and
the ancillary properties of some of the third generation
beta blockers.17 In addition, a nocebo effect, in which a
patient’s knowledge that a drug has been associated with
ED, is often at least as important a contributing factor to
a patient’s ED as any physiological effect, particularly with
contemporary blockers.8 In patients who develop sexual
problems as a result of medication therapy, it can be
helpful to switch to another drug from the same class
or ﬁnd a reasonable alternate strategy.8
Sexual problems can be related to other HF treatment such
as device therapy or heart transplantation.24,25 In a small
study of 31 patients, 29% left ventricular assist device (LVAD)
patients and 71% heart transplant patients reported being
content with sexual activity; however, satisfaction with sex
life was lower in transplant patients compared with HTx
patients (7.6 ± 3.1 for HTx on a visual analogue scale vs. 3.9
± 4.0 for LVAD patients, P = 0.017).24
In addition to HF symptoms, comorbidity, and HF
treatment, several other factors such as psychological fac-
tors (depression, anxiety) can contribute to sexual prob-
lems.5 More general factors that are related to sexual
function might be relevant to consider in the HF popula-
tion as well, such as age, lifestyle, or problems in a
relationship.5,26
Table 1 Issues to consider when advising heart failure patients on sexual activity
General issues
• Choose appropriate setting
• Consider that sexual concerns are normal
• Discuss sexual activity for example within the context of exercise, during uptitration or initiation of medication
• Adapt terminology to the patients and partner
Assessment
• Use open-ended questions
Examples:
General
○Many people with heart failure (or with symptoms like you have) have concerns about resuming sex. What concerns do you have?
○ Some people report sexual problems as a result of prescribing medication. How is this for you?
More speciﬁc
○ Have you noticed any changes in your sexual performance such as problems with erections or orgasm, vaginal dryness, or decreased
desire for sex? If so, how often has this occurred?
• Consider using questionnaires such as Multidimensional Sexual Self-concept Inventory (MSSI) or International Index of Erectile
Function (IIEF) for men or International Index of Erectile Function (IIEF) for women
• Assess more than once if needed during the HF trajectory
Consider the right level of information and support needed
○ Permission
○ Limited information
○ Speciﬁc suggestion
○ Intensive therapy
Referral
• Refer to special trained counsellor, urologist, sexual therapist if needed
• Refer to cardiac rehab
Sexual function and heart failure 5
ESC Heart Failure 2017; 4: 3–7
DOI: 10.1002/ehf2.12108
Energy consumption and risk related to
sexual activity
Most studies on the actual energy consumption of sexual
activity is performed in healthy young couples or normo-
tensive men.27,28 The energy required for sexual activity
depends on its intensity and a person’s physical condition.
In the AHA statement, the physical effort related to sexual
activity in cardiac patients is described to be considered as
mild to moderate physical activity and the related en-
ergy expenditure in the range of three to ﬁve metabolic
units (METs).8 The amount of energy needed for sexual
activity is often compared with the energy needed to
climb three ﬂights of stairs, general housework, or garden-
ing. At the same time, it was found that patients with HF
had a VO2< 10mL/kg/min (i.e. 2.8 MET) and had an im-
paired sexual function.5
BP and heart rate (HR) can increase mildly during fore-
play, with increases occurring transiently during sexual
arousal and the greatest increases occur during the 10
to 15 s of orgasm, and a quick return to baseline BP
and HR.8,27 In HF patients, it was also found that they
had an increased HR, right ventricular pressure, and dia-
stolic pulmonary pressure during sexual activity (especially
during orgasm).29
There is not a lot of data on the risk for exacerbation
in patients’ HF as a result of sexual activity. For patients
deemed to be at high risk, sexual activity should be
deferred until their condition is optimally managed and
stabilized.8 Although some patients approach their
physical limit during sexual activity, patients might still
be able to have sex by their partner actively ensuring that
they practice passive sex or sex helped by drugs or
implants.
Counselling and treatment for sexual
problems in heart failure patients
Some patients with HF might need speciﬁc information
about activities they can undertake, as well as clear infor-
mation and treatment to help cope with sexual prob-
lems.30 Because sexual problems might occur during the
disease trajectory, sexual concerns need to be discussed
more than once during treatment and should become
an integral part of HF management and patient education.
First, HF to be optimally managed and patient’s condition
should be stabilized before they resume sex.8 Further-
more, there are several practical advices that can help pa-
tients to optimally enjoy their sex life and intimacy
(Table 1).
This information needs to be adapted to the personal
situation of patients, sexual preferences, and culture.30,31
One of the approaches that can be used to guide health
professionals in determining needs of patients and in
providing information related to sexuality is the so-called
PLISSIT model32 (Figure 2).
The basic idea of this approach is that all patients with HF
should be given the opportunity to talk about sexual health in
a more general way by informing them that this is an issue
that patients might worry about and that they are welcome
to discuss this with the health care provider. Some patients
might need more information (Limited Information) that ex-
plains some basic facts and general information. From those,
some patients might wish more detailed and speciﬁc infor-
mation (Speciﬁc Suggestion), and even a smaller group might
be in need of referral to specialist (Intensive Therapy)
(Figure 2). Some patients might wish to be treated in case
of ED. Phosphodiesterase type 5 (PDE-5) inhibitors are gener-
ally safe and effective for the treatment of ED in patients with
systemic arterial hypertension, stable coronary artery disease,
and compensated HF.8 However, PDE-5 inhibitors should be
used with caution in cases of intermediate cardiac risk and
should be avoided in patients with high cardiac risk or patients
who are concurrently being treated with nitrates.8
Concluding remarks
Sexual problems are common in men and women with HF
and should be addressed to avoid possible fears and worries,
to proactively prevent problems such as medication
nonadherence or using medications or herbs that might
endanger the health, and to prevent problems in the relation-
ship between patient and partner.
Figure 2 The PLISSIT model to guide education and counselling.32
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